Champions Oncology Insider Trades
NASDAQ: CSBRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 15, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Champions Oncology insider activity
Over the last 12 months, Champions Oncology insiders reported 1 transaction on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows ACKERMAN JOEL (Director) reporting a transaction in 94,405 shares at $2.10 on Oct 30, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CSBR's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CSBR insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 30, 2025 | ACKERMAN JOELDirector | Option exercise | 94,405 | $198.25K | Form 4 |
| Mar 25, 2025 | Breitfeld Philip P.Director | other | 4,150 | — | Form 4 |
| Oct 31, 2024 | ACKERMAN JOELDirector | Option exercise | 16,667 | $90.50K | Form 4 |
| Oct 31, 2024 | ACKERMAN JOELDirector | Option exercise | 88,470 | $185.79K | Form 4 |
| Jan 12, 2024 | Mendelson Daniel NewmanDirector | Buy | 1,000 | $6.50K | Form 4 |
| Jan 11, 2024 | Mendelson Daniel NewmanDirector | Buy | 2,000 | $12.54K | Form 4 |
| Jan 10, 2024 | Mendelson Daniel NewmanDirector | Buy | 2,944 | $18.58K | Form 4 |
| Jan 9, 2024 | Mendelson Daniel NewmanDirector | Buy | 3,000 | $18.75K | Form 4 |
| Jan 8, 2024 | Mendelson Daniel NewmanDirector | Buy | 1,000 | $6.15K | Form 4 |
| Jan 5, 2024 | Mendelson Daniel NewmanDirector | Buy | 2,000 | $12.18K | Form 4 |
| Jan 4, 2024 | Mendelson Daniel NewmanDirector | Buy | 3,000 | $18.36K | Form 4 |
| Jan 3, 2024 | Mendelson Daniel NewmanDirector | Buy | 500 | $2.92K | Form 4 |
| Dec 21, 2023 | Mendelson Daniel NewmanDirector | Buy | 2,500 | $12.30K | Form 4 |
| Dec 20, 2023 | Mendelson Daniel NewmanDirector | Buy | 2,100 | $10.12K | Form 4 |
| Dec 19, 2023 | Mendelson Daniel NewmanDirector | Buy | 5,000 | $23.75K | Form 4 |
| Oct 17, 2023 | ACKERMAN JOELDirector | Option exercise | 114,552 | $240.56K | Form 4 |
| Oct 11, 2023 | Mendelson Daniel NewmanDirector | Buy | 5,000 | $32.00K | Form 4 |
| Oct 10, 2023 | Mendelson Daniel NewmanDirector | Buy | 1,100 | $7.05K | Form 4 |
| Oct 6, 2023 | Mendelson Daniel NewmanDirector | Buy | 1,530 | $9.91K | Form 4 |
| Oct 5, 2023 | Mendelson Daniel NewmanDirector | Buy | 2,000 | $12.94K | Form 4 |
| Sep 29, 2023 | Mendelson Daniel NewmanDirector | Buy | 4,000 | $24.64K | Form 4 |
| Sep 28, 2023 | Mendelson Daniel NewmanDirector | Buy | 5,000 | $31.10K | Form 4 |
| Sep 27, 2023 | Mendelson Daniel NewmanDirector | Buy | 1,500 | $8.93K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4